Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
Primary Purpose
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Aerobic Physical Exercise
Relaxing Physical Exercise
Information about physical exercise
Sponsored by
About this trial
This is an interventional treatment trial for Bipolar Disorder focused on measuring physical exercise, physical activity
Eligibility Criteria
Inclusion Criteria:
- Patients at Psychiatry Southwest, Karolinska University Hospital Region Stockholm Sweden.
- Bipolar disorder
- Ongoing depression
Exclusion Criteria:
- Severe psychiatric disorder such as mania and psychosis
- Medical conditions such as heart- and lung diseases where PE is contraindicated.
- Unable to understand written and spoken Swedish language.
Sites / Locations
- Region Stockholm, Psykiatri Sydväst (Psychiatric Clinic Psychiatry Southwest)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
Braining high intensity
Braining relaxing exercise
Information about physical exercise
Arm Description
Moderate to vigorous physical exercise, supervised by psychiatric staff 3 times per week
Relaxation, light yoga or stretching exercise, supervised by psychiatric staff 3 times per week
Written and oral information about health benefits from physical exercise, provided by researcher on one occasion.
Outcomes
Primary Outcome Measures
PHQ-9 (Patient Health Questionnaire - 9 items)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
PHQ-9 (Patient Health Questionnaire - 9 items)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
PHQ-9 (Patient Health Questionnaire - 9 items)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
PHQ-9 (Patient Health Questionnaire - 9 items)
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Secondary Outcome Measures
AS-18 (Affective self rating scale)
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
AS-18 (Affective self rating scale)
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
AS-18 (Affective self rating scale)
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
AS-18 (Affective self rating scale)
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
YMRS (Young Ziegler Mania Rating Scale)
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
YMRS (Young Ziegler Mania Rating Scale)
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
YMRS (Young Ziegler Mania Rating Scale)
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
YMRS (Young Ziegler Mania Rating Scale)
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
CGI-S (Clinical Global Impressions - Severity Scale)
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
CGI-S (Clinical Global Impressions - Severity Scale)
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
CGI-S (Clinical Global Impressions - Severity Scale)
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
CGI-S (Clinical Global Impressions - Severity Scale)
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Blood pressure
systolic and diastolic, mmHg
Blood pressure
systolic and diastolic, mmHg
Blood pressure
systolic and diastolic, mmHg
Blood pressure
systolic and diastolic, mmHg
Heart rate
Heart rate, beats per minute
Heart rate
Heart rate, beats per minute
Heart rate
Heart rate, beats per minute
Heart rate
Heart rate, beats per minute
BMI (Body mass index)
Weight in kg divided by the square of height in m
BMI (Body mass index)
Weight in kg divided by the square of height in m
BMI (Body mass index)
Weight in kg divided by the square of height in m
BMI (Body mass index)
Weight in kg divided by the square of height in m
Waist circumference
Waist circumference, cm
Waist circumference
Waist circumference, cm
Waist circumference
Waist circumference, cm
Waist circumference
Waist circumference, cm
FBS (fasting blood sugar)
fasting blood sugar, mmol/l
FBS (fasting blood sugar)
fasting blood sugar, mmol/l
FBS (fasting blood sugar)
fasting blood sugar, mmol/l
FBS (fasting blood sugar)
fasting blood sugar, mmol/l
HbA1c (Hemoglobin A1c)
Glycated hemoglobin, mmol/mol
HbA1c (Hemoglobin A1c)
Glycated hemoglobin, mmol/mol
HbA1c (Hemoglobin A1c)
Glycated hemoglobin, mmol/mol
HbA1c (Hemoglobin A1c)
Glycated hemoglobin, mmol/mol
Blood lipids
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Blood lipids
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Blood lipids
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Blood lipids
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
CRP (C-reactive protein)
Measurement of inflammation and infection, mmol/L
CRP (C-reactive protein)
Measurement of inflammation and infection, mmol/L
CRP (C-reactive protein)
Measurement of inflammation and infection, mmol/L
CRP (C-reactive protein)
Measurement of inflammation and infection, mmol/L
Telomere length
telomere length in leukocytes
Telomere length
telomere length in leukocytes
Telomerase
Enzyme activity in blood
Telomerase
Enzyme activity in blood
WHODAS 2.0 (World health organization disability assessment schedule)
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
WHODAS 2.0 (World health organization disability assessment schedule)
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
WHODAS 2.0 (World health organization disability assessment schedule)
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
WHODAS 2.0 (World health organization disability assessment schedule)
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
EQ-5D-5L (EuroQol VAS)
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
EQ-5D-5L (EuroQol VAS)
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
EQ-5D-5L (EuroQol VAS)
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
EQ-5D-5L (EuroQol VAS)
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
SRH (Self-rated health)
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
SRH (Self-rated health)
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
SRH (Self-rated health)
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
SRH (Self-rated health)
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Occupational level measured in % of work ability in medical certificate
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Occupational level measured in % of work ability in medical certificate
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Occupational level measured in % of work ability in medical certificate
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Occupational level measured in % of work ability in medical certificate
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Full Information
NCT ID
NCT05340686
First Posted
March 31, 2022
Last Updated
July 6, 2023
Sponsor
Region Stockholm
Collaborators
Karolinska Institutet
1. Study Identification
Unique Protocol Identification Number
NCT05340686
Brief Title
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
Official Title
Braining - A Randomized Controlled Study on Moderate-vigorous Aerobic Physical Exercise (PE) as an add-on Treatment in Bipolar Disorder. Effects on Recovery Time and Long-term Prevention From Bipolar Depression
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 26, 2022 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
April 20, 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Region Stockholm
Collaborators
Karolinska Institutet
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Hypothesis: the hypothesis of the study is that aerobic physical exercise (PE) performed with the method Braining accelerates recovery from bipolar depression as well as improves psychiatric and somatic health in individuals with bipolar depression Method: a randomized controlled trial with 54 patients with bipolar depression are randomized to 12 weeks of either 1) supervised aerobic PE 3 times/week, 2) supervised relaxation/stretching 3 times/week or 3) information about PE but no supervised activity.
Detailed Description
The hypothesis of this study is that adding aerobic PE might accelerate recovery, reduce negative side effects, improve mental wellbeing and function, increase long term prevention against relapsing bipolar episodes and reduce risk for complications such as cardiovascular disease in patients with bipolar disorder. Furthermore the study aims to evaluate if the effect of PE is linked to biological factors such as genetical factors, stress hormone levels, level of inflammation and other biological markers for health and disease that can be measured in standard blood samples.
Patients diagnosed with bipolar disorder with ongoing depression are invited to participate in the study at regular visits in the psychiatric clinic. All study participants are medicated with mood stabilizers according to routine treatment and receive regular treatment for bipolar depression. After informed consent the study participants will be randomized to one of three groups 1) moderate to vigorous PE group training together with psychiatric staff three times per week 2) relaxing and stretching exercises group training together with psychiatric staff three times per week 3) information about PE and relaxation but no supervised PE or relaxation/stretching, for the 12 weeks of the study period.
BEFORE: The first week consists of pre-test including interview regarding medical history and physical and psychiatric examination, ECG and blood samples. To measure level of physical activity the participants wear an activity monitor, Actiheart, that continuously registers physical activity for 7 days. The study participants will also fill out different questionnaires regarding general health and psychiatric symptoms.
STUDY PERIOD: During the 12 weeks long study period the participants fill out an activity questionnaire and health questionnaires once a week.
AFTER: during the twelfth week of the study period evaluation is being performed with repetition of the physical and psychiatric examination, blood samples and questionnaires. After 1, 2 and 3 years after the exercise period the questionnaires are repeated. Blood samples are repeated one year after the study period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder, Bipolar Affective Disorder; Remission in, Bipolar Affective Disorder, Currently Depressed, Moderate
Keywords
physical exercise, physical activity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized controlled trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
54 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Braining high intensity
Arm Type
Experimental
Arm Description
Moderate to vigorous physical exercise, supervised by psychiatric staff 3 times per week
Arm Title
Braining relaxing exercise
Arm Type
Active Comparator
Arm Description
Relaxation, light yoga or stretching exercise, supervised by psychiatric staff 3 times per week
Arm Title
Information about physical exercise
Arm Type
Active Comparator
Arm Description
Written and oral information about health benefits from physical exercise, provided by researcher on one occasion.
Intervention Type
Behavioral
Intervention Name(s)
Aerobic Physical Exercise
Intervention Description
Moderate to vigorous physical exercise 30-45 minutes in a group setting led by psychiatric staff, 3 times per week for 12 weeks
Intervention Type
Behavioral
Intervention Name(s)
Relaxing Physical Exercise
Intervention Description
Relaxing exercises (stretching, light yoga) 30-45 minutes in a group setting led by psychiatric staff, 3 times per week for 12 weeks
Intervention Type
Behavioral
Intervention Name(s)
Information about physical exercise
Intervention Description
Written and oral information about physical exercise recommendations, on one occasion, by researcher
Primary Outcome Measure Information:
Title
PHQ-9 (Patient Health Questionnaire - 9 items)
Description
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Time Frame
Change from inclusion to follow up 3 months after inclusion
Title
PHQ-9 (Patient Health Questionnaire - 9 items)
Description
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Time Frame
At follow up 12 months after intervention.
Title
PHQ-9 (Patient Health Questionnaire - 9 items)
Description
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Time Frame
At follow up 24 months after intervention.
Title
PHQ-9 (Patient Health Questionnaire - 9 items)
Description
Self rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.
Time Frame
At follow up 36 months after intervention.
Secondary Outcome Measure Information:
Title
AS-18 (Affective self rating scale)
Description
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
Time Frame
Change from inclusion to follow up 3 months after inclusion
Title
AS-18 (Affective self rating scale)
Description
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
Time Frame
At follow up 12 months after intervention.
Title
AS-18 (Affective self rating scale)
Description
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
Time Frame
At follow up 24 months after intervention.
Title
AS-18 (Affective self rating scale)
Description
Self-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
Time Frame
At follow up 36 months after intervention.
Title
YMRS (Young Ziegler Mania Rating Scale)
Description
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
YMRS (Young Ziegler Mania Rating Scale)
Description
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
Time Frame
At follow up 12 months after intervention.
Title
YMRS (Young Ziegler Mania Rating Scale)
Description
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
Time Frame
At follow up 24 months after intervention.
Title
YMRS (Young Ziegler Mania Rating Scale)
Description
Interviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
Time Frame
At follow up 36 months after intervention.
Title
CGI-S (Clinical Global Impressions - Severity Scale)
Description
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
CGI-S (Clinical Global Impressions - Severity Scale)
Description
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Time Frame
At follow up 12 months after intervention
Title
CGI-S (Clinical Global Impressions - Severity Scale)
Description
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Time Frame
At follow up 24 months after intervention
Title
CGI-S (Clinical Global Impressions - Severity Scale)
Description
A one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Time Frame
At follow up 36 months after intervention
Title
Blood pressure
Description
systolic and diastolic, mmHg
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Blood pressure
Description
systolic and diastolic, mmHg
Time Frame
At follow up 12 months after intervention
Title
Blood pressure
Description
systolic and diastolic, mmHg
Time Frame
At follow up 24 months after intervention
Title
Blood pressure
Description
systolic and diastolic, mmHg
Time Frame
At follow up 36 months after intervention
Title
Heart rate
Description
Heart rate, beats per minute
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Heart rate
Description
Heart rate, beats per minute
Time Frame
At follow up 12 months after intervention
Title
Heart rate
Description
Heart rate, beats per minute
Time Frame
At follow up 24 months after intervention
Title
Heart rate
Description
Heart rate, beats per minute
Time Frame
At follow up 36 months after intervention
Title
BMI (Body mass index)
Description
Weight in kg divided by the square of height in m
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
BMI (Body mass index)
Description
Weight in kg divided by the square of height in m
Time Frame
At follow up 12 months after intervention
Title
BMI (Body mass index)
Description
Weight in kg divided by the square of height in m
Time Frame
At follow up 24 months after intervention
Title
BMI (Body mass index)
Description
Weight in kg divided by the square of height in m
Time Frame
At follow up 36 months after intervention
Title
Waist circumference
Description
Waist circumference, cm
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Waist circumference
Description
Waist circumference, cm
Time Frame
At follow up 12 months after intervention
Title
Waist circumference
Description
Waist circumference, cm
Time Frame
At follow up 24 months after intervention
Title
Waist circumference
Description
Waist circumference, cm
Time Frame
At follow up 36 months after intervention
Title
FBS (fasting blood sugar)
Description
fasting blood sugar, mmol/l
Time Frame
Change from inclusion to follow up 3 months after inclusion
Title
FBS (fasting blood sugar)
Description
fasting blood sugar, mmol/l
Time Frame
At follow up 12 months after intervention.
Title
FBS (fasting blood sugar)
Description
fasting blood sugar, mmol/l
Time Frame
At follow up 24 months after intervention.
Title
FBS (fasting blood sugar)
Description
fasting blood sugar, mmol/l
Time Frame
At follow up 36 months after intervention.
Title
HbA1c (Hemoglobin A1c)
Description
Glycated hemoglobin, mmol/mol
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
HbA1c (Hemoglobin A1c)
Description
Glycated hemoglobin, mmol/mol
Time Frame
At follow up 12 months after intervention.
Title
HbA1c (Hemoglobin A1c)
Description
Glycated hemoglobin, mmol/mol
Time Frame
At follow up 24 months after intervention.
Title
HbA1c (Hemoglobin A1c)
Description
Glycated hemoglobin, mmol/mol
Time Frame
At follow up 36 months after intervention.
Title
Blood lipids
Description
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Blood lipids
Description
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Time Frame
At follow up 12 months after intervention.
Title
Blood lipids
Description
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Time Frame
At follow up 24 months after intervention.
Title
Blood lipids
Description
Total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
Time Frame
At follow up 36 months after intervention.
Title
CRP (C-reactive protein)
Description
Measurement of inflammation and infection, mmol/L
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
CRP (C-reactive protein)
Description
Measurement of inflammation and infection, mmol/L
Time Frame
At follow up 12 months after intervention.
Title
CRP (C-reactive protein)
Description
Measurement of inflammation and infection, mmol/L
Time Frame
At follow up 24 months after intervention.
Title
CRP (C-reactive protein)
Description
Measurement of inflammation and infection, mmol/L
Time Frame
At follow up 36 months after intervention.
Title
Telomere length
Description
telomere length in leukocytes
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Telomere length
Description
telomere length in leukocytes
Time Frame
At follow up 12 months after intervention.
Title
Telomerase
Description
Enzyme activity in blood
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Telomerase
Description
Enzyme activity in blood
Time Frame
At follow up 12 months after intervention.
Title
WHODAS 2.0 (World health organization disability assessment schedule)
Description
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
WHODAS 2.0 (World health organization disability assessment schedule)
Description
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
Time Frame
At follow up 12 months after intervention.
Title
WHODAS 2.0 (World health organization disability assessment schedule)
Description
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
Time Frame
At follow up 24 months after intervention.
Title
WHODAS 2.0 (World health organization disability assessment schedule)
Description
Self rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
Time Frame
At follow up 36 months after intervention.
Title
EQ-5D-5L (EuroQol VAS)
Description
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
EQ-5D-5L (EuroQol VAS)
Description
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
Time Frame
At follow up 12 months after intervention.
Title
EQ-5D-5L (EuroQol VAS)
Description
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
Time Frame
At follow up 24 months after intervention.
Title
EQ-5D-5L (EuroQol VAS)
Description
Self-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
Time Frame
At follow up 36 months after intervention.
Title
SRH (Self-rated health)
Description
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
SRH (Self-rated health)
Description
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
Time Frame
At follow up 12 months after intervention.
Title
SRH (Self-rated health)
Description
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
Time Frame
At follow up 24 months after intervention.
Title
SRH (Self-rated health)
Description
SRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
Time Frame
At follow up 36 months after intervention.
Title
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Description
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Description
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Time Frame
At follow up 12 months after intervention.
Title
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Description
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Time Frame
At follow up 24 months after intervention.
Title
BBQ (Brunnsviken Brief Quality of Life Questionnaire)
Description
Self rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Time Frame
At follow up 36 months after intervention.
Title
Occupational level measured in % of work ability in medical certificate
Description
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Time Frame
change from inclusion to follow up 3 months after inclusion
Title
Occupational level measured in % of work ability in medical certificate
Description
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Time Frame
At follow up 12 months after intervention.
Title
Occupational level measured in % of work ability in medical certificate
Description
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Time Frame
At follow up 24 months after intervention.
Title
Occupational level measured in % of work ability in medical certificate
Description
Complete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.
Time Frame
At follow up 36 months after intervention.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients at Psychiatry Southwest, Karolinska University Hospital Region Stockholm Sweden.
Bipolar disorder
Ongoing depression
Exclusion Criteria:
Severe psychiatric disorder such as mania and psychosis
Medical conditions such as heart- and lung diseases where PE is contraindicated.
Unable to understand written and spoken Swedish language.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Åsa Anger, MD
Phone
+46858580445
Email
asa.susanna.anger@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lina Martinsson, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Region Stockholm, Psykiatri Sydväst (Psychiatric Clinic Psychiatry Southwest)
City
Stockholm
ZIP/Postal Code
14186
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Åsa Anger, MD
Email
asa.susanna.anger@ki.se
First Name & Middle Initial & Last Name & Degree
Anna Wallerblad, MD
Email
anna.wallerblad@yahoo.com
First Name & Middle Initial & Last Name & Degree
Lina Martinsson, PhD
12. IPD Sharing Statement
Learn more about this trial
Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression
We'll reach out to this number within 24 hrs